BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20021455)

  • 1. E2F1-mediated apoptosis as a target of cancer therapy.
    Wu Z; Yu Q
    Curr Mol Pharmacol; 2009 Jun; 2(2):149-60. PubMed ID: 20021455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E2F family and the role of E2F1 in apoptosis.
    Wu Z; Zheng S; Yu Q
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2389-97. PubMed ID: 19539777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
    Engelmann D; Pützer BM
    Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation.
    Pickering MT; Kowalik TF
    Oncogene; 2006 Feb; 25(5):746-55. PubMed ID: 16186801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy.
    Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A
    Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis.
    Wong CH; Wu Z; Yu Q
    Oncogene; 2014 Mar; 33(10):1249-57. PubMed ID: 23542171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
    Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
    Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 apoptosis counterattacked: evil strikes back.
    Pützer BM; Engelmann D
    Trends Mol Med; 2013 Feb; 19(2):89-98. PubMed ID: 23219173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells.
    Sun B; Wingate H; Swisher SG; Keyomarsi K; Hunt KK
    Cell Cycle; 2010 Mar; 9(6):1122-30. PubMed ID: 20237430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 is the target of a UV-inducible apoptosis switch and a node for UV signaling.
    Knezevic D; Zhang W; Rochette PJ; Brash DE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11286-91. PubMed ID: 17586682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR signaling inhibits E2F1-induced apoptosis in vivo: implications for cancer therapy.
    Ginsberg D
    Sci STKE; 2007 Jan; 2007(371):pe4. PubMed ID: 17264315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
    Liontos M; Niforou K; Velimezi G; Vougas K; Evangelou K; Apostolopoulou K; Vrtel R; Damalas A; Kontovazenitis P; Kotsinas A; Zoumpourlis V; Tsangaris GT; Kittas C; Ginsberg D; Halazonetis TD; Bartek J; Gorgoulis VG
    Am J Pathol; 2009 Jul; 175(1):376-91. PubMed ID: 19541929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.
    Zhang XP; Liu F; Wang W
    J Biol Chem; 2010 Oct; 285(41):31571-80. PubMed ID: 20685653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
    Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
    Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution.
    Iglesias-Ara A; Zenarruzabeitia O; Buelta L; Merino J; Zubiaga AM
    Cell Death Differ; 2015 Oct; 22(10):1577-89. PubMed ID: 25656653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression level is a key determinant of E2F1-mediated cell fate.
    Shats I; Deng M; Davidovich A; Zhang C; Kwon JS; Manandhar D; Gordân R; Yao G; You L
    Cell Death Differ; 2017 Apr; 24(4):626-637. PubMed ID: 28211871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human ARF binds E2F1 and inhibits its transcriptional activity.
    Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
    Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.